|
Advances in the Use of Aromatase Inhibitors in the Treatment of Breast CancerNCCN 3rd Annual Congress: Hematologic Malignancies - Treatment of Cutaneous T-Cell LymphomaNCCN 3rd Annual Congress: Hematologic Malignancies – Chronic Myelogenous Leukemia NCCN Clinical Practice Guidelines in Oncology Symposium: Breast CancerNCCN Clinical Practice Guidelines in Oncology Symposium: Colon and Rectal CancersNCCN Clinical Practice Guidelines in Oncology Symposium: Kidney CancerNCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung CancerNCCN Colon and Rectal Cancers Guidelines UpdateNCCN Kidney Cancer Guidelines UpdateNCCN Task Force Report: Bone Health in Cancer CareNCCN Task Force Report: Breast Cancer in the Older WomanNCCN Task Force Report: Integration of ER/PR Tumor Markers
into Treatment Planning for Breast CancerNCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated with EGFR Inhibition in Patients with CancerNCCN Task Force Report: Molecular Markers in Leukemia and LymphomaNew Advances in Risk Reduction for Recurrence of Breast Cancer in Premenopausal WomenNew Advances in the First-Line Treatment of Non-Small Cell Lung CancerSequencing Choices in the Treatment of Multiple MyelomaSequencing of Drugs in the Treatment of Kidney Cancer
|
